Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection
暂无分享,去创建一个
S. Qiu | Jia Fan | Jian Zhou | Z. Ren | SuSu Zheng | Hu-jia Shen | Yong Yi | Yi-Peng Fu | Jin-Long Huang | Chu-Yu Jing | Jia-jia Lin | Xin Xu | Juan Zhang | Bo-Heng Zhang
[1] M. Smolkin,et al. Prognostic value of albumin in patients with head and neck cancer , 2016, The Laryngoscope.
[2] Lequn Li,et al. Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma , 2016, The British journal of surgery.
[3] Y. Huang,et al. Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer , 2016, Medicine.
[4] S. Qiu,et al. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection , 2016, Medicine.
[5] G. Cooke,et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.
[6] Z. Wang,et al. Negative Impact of Preoperative Platelet-Lymphocyte Ratio on Outcome After Hepatic Resection for Intrahepatic Cholangiocarcinoma , 2015, Medicine.
[7] K. Koike,et al. The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.
[8] B. Sangro,et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Jia Fan,et al. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy , 2015, Tumor Biology.
[10] V. Wong,et al. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma , 2015, Disease markers.
[11] X. Salvatella,et al. Human serum albumin, systemic inflammation, and cirrhosis. , 2014, Journal of hepatology.
[12] T. Pawlik,et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.
[13] T. Pawlik,et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. , 2014, JAMA surgery.
[14] S. Ye,et al. γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.
[15] T. Joh,et al. Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle , 2014, International journal of molecular sciences.
[16] S. Qiu,et al. Elevation of serum &ggr;-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study , 2013, European journal of gastroenterology & hepatology.
[17] J. Everhart,et al. Association of γ‐glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV) , 2013, Hepatology.
[18] Kui Wang,et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Mira,et al. Specific antioxidant properties of human serum albumin , 2013, Annals of Intensive Care.
[20] I. Fentiman. Gamma-glutamyl transferase: risk and prognosis of cancer , 2012, British Journal of Cancer.
[21] B. North,et al. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) , 2012, British Journal of Cancer.
[22] N. Concin,et al. Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial , 2012, British Journal of Cancer.
[23] N. Concin,et al. Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer. , 2011, Gynecologic oncology.
[24] F. Pruvot,et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma , 2011, Cancer.
[25] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[26] Y. Maehara,et al. p62+ Hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease. , 2010, American journal of clinical pathology.
[27] O. Farges,et al. Clinical presentation and management of intrahepatic cholangiocarcinoma. , 2010, Gastroenterologie clinique et biologique.
[28] Zhao-You Tang,et al. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation , 2009, Journal of Gastroenterology.
[29] I. Endo,et al. Intrahepatic cholangiocarcinoma , 2014, Radiopaedia.org.
[30] E. Elkin,et al. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[31] J. West,et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001 , 2006, British Journal of Cancer.
[32] F. Stickel,et al. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress , 2006, Biological chemistry.
[33] G. Kaysen,et al. POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition , 2004, Seminars in dialysis.
[34] D. Jacobs,et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? , 2004, Free radical biology & medicine.
[35] Dean P. Jones,et al. Extracellular thiols and thiol/disulfide redox in metabolism. , 2004, Annual review of nutrition.
[36] H. El‐Serag,et al. The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.
[37] S. Yamasaki. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. , 2003, Journal of hepato-biliary-pancreatic surgery.
[38] M. Makuuchi,et al. A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.
[39] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[40] J. Hafkenscheid,et al. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. , 1987, The Journal of clinical investigation.
[41] N. Meydan,et al. Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[42] Y. Maehara,et al. p 62-positive Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated with Viral Hepatitis or Alcoholic Liver Disease Running title : Hyaline inclusions in cholangiocarcinoma , 2013 .
[43] York Springer,et al. Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .
[44] M. Choti,et al. A Proposed Staging System for Intrahepatic Cholangiocarcinoma , 2008, Annals of Surgical Oncology.